Viridian Therapeutics Overview
Viridian Therapeutics Target Price
Analysts' 12-month price predictions for VRDN.
Get informed when a big investor buys or sells
+ FollowShare Price
$19.08
Average Target Price
$35.00
83.4% upside
83.4% upside11 analysts in the last 4 months
High: $43 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-30 | Truist Financial | $38 | 99.2% upside |  |
| 2026-06-30 | Goldman Sachs | $39 | 104.4% upside | |
| 2026-06-29 | WedbushLaura Chico | $43 | 125.4% upside | |
| 2026-06-29 | Truist FinancialGreg Renza | $35 | 83.4% upside | |
| 2026-06-29 | Wells FargoDerek Archila | $31 | 62.5% upside | |
| 2026-05-15 | Evercore ISI | $26 | 36.3% upside | |
| 2026-05-13 | Stifel Nicolaus | $39 | 104.4% upside | |
| 2026-05-06 | RBC Capital | $34 | 78.2% upside | |
| 2026-04-21 | Truist Financial | $33 | 73% upside | |
| 2026-04-08 | Truist Financial | $36 | 88.7% upside | |
| 2026-04-08 | WedbushLaura Chico | $31 | 62.5% upside | |
| 2026-02-26 | JefferiesKelly Shi | $45 | 135.8% upside | |
| 2026-01-28 | Evercore ISIGavin Clark-Gartner | $45 | 135.8% upside | |
| 2026-01-20 | Evercore ISIGavin Clark-Gartner | $44 | 130.6% upside | |
| 2026-01-07 | UBS | $50 | 162.1% upside | |
| 2025-12-03 | William Blair | $47 | 146.3% upside | |
| 2025-11-24 | Truist Financial | $41 | 114.9% upside | |
| 2025-11-06 | RBC Capital | $45 | 135.8% upside | |
| 2025-11-06 | Goldman Sachs | $40 | 109.6% upside | |
| 2025-11-05 | Stifel NicolausAlex Thompson | $48 | 151.6% upside | |
| 2025-10-21 | Oppenheimer | $36 | 88.7% upside | |
| 2025-10-21 | H.C. WainwrightDouglas Tsao | $34 | 78.2% upside | |
| 2024-11-12 | Stifel NicolausAlex Thompson | $20.5 | 7.4% upside | |
| 2024-09-13 | RBC CapitalGregory Renza | $22 | 15.3% upside | |
| 2024-09-11 | NeedhamSerge Belanger | $19 |  0.4% downside | |
| 2024-09-11 | B.Riley FinancialKalpit Patel | $22 | 15.3% upside | |
| 2024-09-10 | Stifel NicolausAlex Thompson | $20 | 4.8% upside | |
| 2024-09-10 | BTIGJulian Harrison | $28 | 46.8% upside | |
| 2024-08-14 | Goldman SachsRichard Law | $25 | 31% upside | |
| 2024-06-11 | RBC CapitalGregory Renza | $17.5 | 8.3% downside | |
| 2024-06-11 | BTIGJulian Harrison | $23 | 20.5% upside | |
| 2024-06-10 | Wolfe ResearchAndy Chen | $14.5 | 24% downside | |
| 2024-06-06 | Goldman SachsRichard Law | $11.5 | 39.7% downside | |
| 2024-05-09 | OppenheimerLeland Gershell | $15.5 | 18.8% downside | |
| 2024-05-09 | H.C. WainwrightDouglas Tsao | $13.5 | 29.2% downside | |
| 2024-05-09 | B.Riley FinancialKalpit Patel | $20 | 4.8% upside | |
| 2023-01-09 | Leerink Partners | $45 | 135.8% upside | |
| 2022-12-19 | Needham | $45 | 135.8% upside | |
| 2022-12-16 | Credit Suisse | $25.5 | 33.6% upside | |
| 2022-12-01 | H.C. Wainwright | $35 | 83.4% upside | |
| 2022-11-15 | JMP Securities | $23 | 20.5% upside | |